Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

A Study to Evaluate AZD2693 in Participants Who Are Carriers of the PNPLA3 148M Risk Allele With Non-cirrhotic Non-alcoholic Steatohepatitis With Fibrosis

ClinicalTrials.gov ID: NCT05809934

Public ClinicalTrials.gov record NCT05809934. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 4:50 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomised, Double-blind, Placebo-controlled, Multi-centre Phase 2b Study to Evaluate the Efficacy, Safety and Tolerability of AZD2693 in Participants With Non-cirrhotic Non-alcoholic Steatohepatitis (NASH) With Fibrosis Who Are Carriers of the PNPLA3 rs738409 148M Risk Allele

Study identification

NCT ID
NCT05809934
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
AstraZeneca
Industry
Enrollment
220 participants

Conditions and interventions

Interventions

  • AZD2693 Drug
  • Placebo Other

Drug · Other

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 14, 2023
Primary completion
Jul 13, 2025
Completion
Sep 28, 2025
Last update posted
Oct 27, 2025

2023 – 2025

United States locations

U.S. sites
37
U.S. states
15
U.S. cities
36
Facility City State ZIP Site status
Research Site Chandler Arizona 85224
Research Site Peoria Arizona 85381
Research Site Surprise Arizona 85378
Research Site Tucson Arizona 85712
Research Site Tucson Arizona 85715
Research Site Gardena California 90247
Research Site La Mesa California 91942
Research Site Lancaster California 93534
Research Site Los Angeles California 90057
Research Site Montclair California 91763
Research Site Orange California 92868
Research Site Rialto California 92377
Research Site Santa Ana California 92704
Research Site Boca Raton Florida 33434
Research Site Hialeah Florida 33016
Research Site Jacksonville Florida 32216
Research Site Port Orange Florida 32127
Research Site Winter Park Florida 32792
Research Site Marietta Georgia 30060
Research Site Topeka Kansas 66606
Research Site Detroit Michigan 48202
Research Site Las Vegas Nevada 89101
Research Site Westlake Ohio 44145
Research Site Chickasha Oklahoma 73018
Research Site Hershey Pennsylvania 17033
Research Site Summerville South Carolina 29485
Research Site Cordova Tennessee 38018
Research Site Austin Texas 78757
Research Site Brownsville Texas 78520
Research Site Denison Texas 75020
Research Site Edinburg Texas 78539
Research Site Houston Texas 77030
Research Site Red Oak Texas 75154
Research Site San Antonio Texas 78229
Research Site Sugar Land Texas 77479
Research Site Richmond Virginia 23249
Research Site Seattle Washington 98105

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 127 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05809934, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 27, 2025 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05809934 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →